Lung cancer CT screening efficacy beyond the NLST screening period
Principal Investigator
Name
Anton Schreuder
Degrees
M.D.
Institution
Radboudumc
Position Title
Clinical Ph.D. student
About this CDAS Project
Study
NLST
(Learn more about this study)
Project ID
NLST-598
Initial CDAS Request Approval
Nov 13, 2019
Title
Lung cancer CT screening efficacy beyond the NLST screening period
Summary
The NLST recently published their extended follow-up lung cancer incidence and mortality outcomes. We plan on performing additional analysis of this extended follow-up data to show the outcomes between the CT and x-ray cohorts when excluding the first four or five years after the baseline scan, i.e., by excluding all events that occured before the fourth or fifth year of follow-up.
Aims
- To perform survival analysis comparing the CT and x-ray cohorts beyond four or five years after the baseline screening round.
- To assess the distribution of lung cancer staging at diagnosis beyond four or five years after the baseline screening round.
Collaborators
Bram van Ginneken, Radboudumc
Colin Jacobs, Radboudumc
Cornelia Schaefer-Prokop, Radboudumc
Mathias Prokop, Radboudumc
Ernst Scholten, Radboudumc
Anton Schreuder, Radboudumc
Related Publications
-
Microsimulation modeling of extended annual CT screening among lung cancer cases in the National Lung Screening Trial.
Schreuder A, Mets OM, Schaefer-Prokop CM, Jacobs C, Prokop M
Lung Cancer. 2021 Apr 8; Volume 156: Pages 5-11 PUBMED